
Wienbrandt L et al., Nature Genetics - Most genetic studies read only a fraction of the genome and infer the rest from a reference panel. This episode covers a new panel built from whole-genome sequencing of 490,319 UK Biobank participants, benchmarked against the TOPMed r3 panel across 35 datasets and used to reanalyze COVID-19 association studies from four European countries. Key terms: genotype imputation, haplotype reference panel, UK Biobank, EagleImp, COVID-19 GWAS.
Study Highlights:
Researchers phased whole-genome data from 490,319 UK Biobank participants into reference panels of more than 361 million variants and extended EagleImp to run on a standalone server and inside the UK Biobank Research Analysis Platform. Compared with the TOPMed r3 panel of 133,597 individuals, the UK Biobank panel achieved lower phasing switch error rates for all superpopulations except AMR and for 25 of 26 1000 Genomes subpopulations. Mean absolute error improved for 4 of 5 superpopulations and 12 subpopulations, while TOPMed performed better across all frequency categories in AFR. Estimated R2 improved across all 5 superpopulations and 22 subpopulations for variants down to 0.01% frequency, with the largest gain, +24.39%, in East Asian samples. Reimputing an Italian severe COVID-19 study of 835 cases and 1,255 controls yielded a genome-wide significant association at 3p21.31 and a new lead SNP, rs73064425, that matched three independent studies.
Conclusion:
The authors conclude that the UK Biobank panel is the most suitable panel for imputing worldwide populations when no population-specific panel is available, and that common-variant imputation is not yet saturated in the European populations tested. The benchmark has limits: estimated imputation R2 stays low for most subpopulations below 0.01% frequency, truth-based measures may be inaccurate at low frequencies, and TOPMed r3 still performed better in AFR on mean absolute error and holds more panel-specific variants.
Article title:
A haplotype reference panel constructed from 490,319 UK Biobank genomes improves genotype imputation for global populations
First author:
Wienbrandt L
Journal:
Nature Genetics
DOI:
10.1038/s41588-026-02819-0
Reference:
Wienbrandt L., Prieß C., Schmöhl M., Neff V., Gretsova M., Torres G., et al. A haplotype reference panel constructed from 490,319 UK Biobank genomes improves genotype imputation for global populations. Nature Genetics. (2026). https://doi.org/10.1038/s41588-026-02819-0
License:
This episode is based on an open-access article published under the Creative Commons Attribution 4.0 International License (CC BY 4.0) – https://creativecommons.org/licenses/by/4.0/
Support:
Base by Base is independent and ad-free — no sponsors, no paywall. If an episode was worth your time, chip in and keep the papers audited and the original songs coming:
❤️ Support monthly: https://buy.stripe.com/cNifZhclVebvagk2JDgEg01
☕ One-time donation: https://donate.stripe.com/7sY4gz71B2sN3RWac5gEg00
▶️ Watch with chapters on YouTube: https://www.youtube.com/@basebybase
More at basebybase.com
On PaperCast Base by Base you'll discover the latest in genomics, functional genomics, structural genomics, and proteomics.
Episode link: https://basebybase.com/episodes/uk-biobank-haplotype-reference-panel-imputation
QC:
This episode's script was checked sentence by sentence against the full text of the original article, by an automated process with human review, before it was recorded.
QC Summary:
- sentences checked: 176
- supported by the article: 143
- flagged and reviewed by a human: 33
- metadata checks passed: 4 of 4
QC result: Warn.
Chapters
- (00:00:03) - The Restorer Analogy: Imputation Explained
- (00:01:03) - Genotyping Chips and the Need for Imputation
- (00:02:16) - Introducing the Study and Its Authors
- (00:02:55) - What Haplotypes Are and How Imputation Works
- (00:03:44) - Limits of Existing Panels: Access and Scale
- (00:04:37) - Is Imputation Already Saturated?
- (00:05:20) - Building the UK Biobank Panel
- (00:06:38) - Creating the Lighter Panel and Software Tools
- (00:07:11) - Designing the Benchmark
- (00:08:39) - Phasing Results: UK Biobank vs TopMed
- (00:09:49) - Checking Against Known Truth: Mixed Results
- (00:10:38) - Testing on Real GWAS Datasets
- (00:11:14) - Speed and Efficiency Gains
- (00:11:52) - The Italian COVID-19 Case Study
- (00:13:12) - Fine-Mapping the Causal Variant
- (00:13:53) - Revisiting the Saturation Question
- (00:14:58) - Limitations of the Study
- (00:15:35) - Remaining Gaps and Future Directions
- (00:16:12) - Conclusion: What the Bigger Archive Reveals
More episodes from "Base by Base"



Don't miss an episode of “Base by Base” and subscribe to it in the GetPodcast app.








